Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy
@article{TLCR41144, author = {Kenichi Suda and Tetsuya Mitsudomi}, title = {Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy}, journal = {Translational Lung Cancer Research}, volume = {9}, number = {6}, year = {2020}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/41144} }